Article
Oncology
Hiroki Kurata, Kensuke Mitsunari, Tsubasa Kondo, Masahito Masato, Hidenori Ito, Yuta Mukae, Yuichiro Nakamura, Tomohiro Matsuo, Kojiro Ohba, Yasushi Mochizuki, Hideki Sakai, Yasuyoshi Miyata
Summary: This study found that the expression of WWC1 protein was negatively associated with tumor grade, pT stage, cell proliferation, and expression of matrix metalloproteinase in patients with upper urinary tract cancer. WWC1 could be a useful predictor and therapeutic target in these patients.
ANTICANCER RESEARCH
(2022)
Article
Pathology
Kazuki Kawamura, Kosuke Miyai, Junichi Asakuma, Kimiya Sato, Susumu Matsukuma, Hitoshi Tsuda, Keiichi Ito
Summary: High tumor budding is associated with poor prognosis in upper urinary tract urothelial carcinoma (UUTUC) patients, and may serve as a novel predictive prognostic factor.
Article
Oncology
Tzu Shuang Chen, Yen Ta Chen, Hung Jen Wang, Po Hui Chiang, Wen Chou Yang, Wei Ching Lee, Yao Chi Chuang, Yuan Tso Cheng, Chih Hsiung Kang, Wei Chia Lee, Chien Hsu Chen, Yuan Chi Shen, Yi Yang Liu, Hui Ying Liu, Yin Lun Chang, Yu Li Su, Chun Chieh Huang, Hao Lun Luo
Summary: This study evaluated the impact of tumor location on cancer outcomes in pT3N0M0 UTUC patients treated with RNU. The results showed that ureter tumors were associated with worse oncological outcomes, especially with local recurrence.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Kosuke Miyai, Kazuki Kawamura, Keiichi Ito, Susumu Matsukuma, Hitoshi Tsuda
Summary: The study revealed that high stromal periostin expression in invasive UTUCs is associated with adverse clinicopathological factors and may be a useful predictor for patient outcomes.
Article
Oncology
Hui-Ying Liu, Yen Ta Chen, Shun-Chen Huang, Hung-Jen Wang, Yuan-Tso Cheng, Chih Hsiung Kang, Wei Ching Lee, Yu-Li Su, Chun-Chieh Huang, Yin-Lun Chang, Yao-Chi Chuang, Hao Lun Luo, Po Hui Chiang
Summary: This study assessed the association of tumor architecture with cancer recurrence, metastasis, and cancer-specific survival in UTUC patients treated with RNU. Results showed a significant association between tumor architecture and various disease features and prognosis factors. Papillary and sessile tumor architecture were independent predictors of metastatic disease and CSS.
FRONTIERS IN ONCOLOGY
(2021)
Article
Medicine, General & Internal
Yin Lun Chang, Yen Ta Chen, Hung Hen Wang, Po Hui Chiang, Yuan Tso Cheng, Chih Hsiung Kang, Yao Chi Chuang, Wei Chin Lee, Wen Chou Yang, Hui Ying Liu, Yu Li Su, Chun Chieh Huang, Sung Min Tse, Hao Lun Luo
Summary: Lymphovascular invasion (LVI) is associated with poor survival in patients with upper urinary tract urothelial carcinoma (UT-UC). This study used propensity score weighting to evaluate the relationship between LVI and patient prognosis. The results showed that LVI predicts metastasis-free survival, cancer-specific survival, and overall survival in UT-UC patients.
Article
Oncology
Han Chen, Ming Wang, Tonghui Weng, Yu Wei, Chuan Liu, Lei Yang, Ke Ren, Yi Tang, Zhaobing Tang, Xin Gou
Summary: In patients with UTUC, high expression of Tim-3 is associated with poor clinical outcomes, including earlier intravesical recurrence and shorter overall survival, while high PD-1 expression is only related to earlier recurrence. Tim-3 plays a more significant role in tumor recurrence and progression compared to PD-1.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
(2021)
Article
Medicine, General & Internal
Antonio Tufano, Nadia Cordua, Valerio Nardone, Raffaele Ranavolo, Rocco Simone Flammia, Federica D'Antonio, Federica Borea, Umberto Anceschi, Costantino Leonardo, Andrea Morrione, Antonio Giordano
Summary: This study investigated the prognostic value of site-specific metastases in patients with metastatic upper tract urothelial carcinoma (mUTUC) and its association with survival outcomes. The results showed that distant lymph nodes were the most common site of single-organ metastasis in mUTUC patients. Patients with liver metastases and multiple organ metastases had worse survival outcomes. Additionally, chemotherapy and radical nephroureterectomy (RNU) were identified as predictors of better survival outcomes in mUTUC patients.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Oncology
Hau-Chern Jan, Kuan-Yu Wu, Ta-Yao Tai, Han-Yu Weng, Wen-Horn Yang, Chien-Hui Ou, Che-Yuan Hu
Summary: The combination of lymphovascular invasion (LVI) and systemic immune-inflammation index (SII) has been shown to be a potential predictor of poor outcomes in localized upper tract urothelial carcinoma (UTUC) patients. In clinical practice, the combined use of LVI and SII can serve as a complementary factor to TNM staging for prognostic assessment of UTUC patients.
CANCER MANAGEMENT AND RESEARCH
(2022)
Article
Medicine, General & Internal
Wojciech Polom, Wojciech Cytawa, Anna Polom, Mikolaj Frankiewicz, Edyta Szurowska, Piotr Lass, Marcin Matuszewski
Summary: The study evaluated the possibility of detecting sentinel lymph nodes in patients with suspicion of upper tract urothelial carcinoma using a radioisotope-based technique. Results showed that detecting SLNs in the upper urinary tract is possible yet challenging, with only 2 out of 19 cases detecting SLNs. Most cases did not show lymphatic outflow.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Biochemistry & Molecular Biology
Cheng-Fa Yeh, Ti-Chun Chan, Hung-Lung Ke, Tzu-Ju Chen, Li-Ching Wu, Hsiang-Ying Lee, Yu-Ching Wei, Wen-Jeng Wu, Chien-Feng Li, Wei-Ming Li
Summary: The study revealed that high ROR2 expression is associated with aggressive pathological characteristics in UC and independently predicts worse prognosis, suggesting its potential role in clinical risk stratification and treatment decisions.
Article
Urology & Nephrology
Francesco Sanguedolce, Matteo Fontana, Morena Turco, Angelo Territo, Josep Balana Lucena, Julio Calderon Cortez, Davide Vanacore, Jacopo Meneghetti, Andrea Gallioli, Josep M. Gaya, Joan Palou Redorta, Alberto Breda
Summary: Appropriate risk stratification and complete tumor ablation are crucial for optimizing oncologic outcomes in patients with upper urinary tract urothelial carcinoma. Latest endourologic technologies can help identify risk factors for tumor recurrence and progression in UTUC patients.
JOURNAL OF ENDOUROLOGY
(2021)
Article
Oncology
Yulong Pan, Zeyu Chen, Lanqing Yang, Xingyuan Wang, Zeng Yi, Liang Zhou, Yongjiang Chen, Lu Yang, Hui Zhuo, Yige Bao, Qiang Wei
Summary: The study assessed the association between body composition and prognosis in UTUC patients treated with radical nephroureterectomy. Body composition parameters were found to be independent predictors of prognosis, aiding in patient stratification and postoperative treatment optimization.
FRONTIERS IN ONCOLOGY
(2021)
Article
Oncology
Thomas van Doeveren, Jose A. Nakauma-Gonzalez, Andrew S. Mason, Geert J. L. H. van Leenders, Tahlita C. M. Zuiverloon, Ellen C. Zwarthoff, Isabelle C. Meijssen, Angelique C. van der Made, Antoine G. van Der Heijden, Kees Hendricksen, Bas W. G. van Rhijn, Charlotte S. Voskuilen, Job van Riet, Winand N. M. Dinjens, Hendrikus J. Dubbink, Harmen J. G. van de Werken, Joost L. Boormans
Summary: By sequencing genes in 15 UTUC patients treated by RNU, it was found that the majority of patients had a clonal relationship between UTUC and subsequent UCB, supporting the idea that UCBs following UTUC surgery are primarily clonally derived recurrences.
INTERNATIONAL JOURNAL OF CANCER
(2021)
Article
Public, Environmental & Occupational Health
Jing-Rong Jhuang, Po-Chun Chiu, Tung-Che Hsieh, Chung-Hsin Chen, Yeong-Shiau Pu, Wen-Chung Lee
Summary: This study investigated the latency period between AA exposure and UTUC development and found that the risk of UTUC decreased after the ban on AA in Taiwan. The latency periods of UTUC varied with age, the dose of AA exposure, and sex, with 9 years for middle-aged women and 8 years for middle-aged men with moderate AA exposure.
FRONTIERS IN PUBLIC HEALTH
(2023)
Article
Oncology
N. Hayakawa, E. Kikuchi, S. Mikami, K. Fukumoto, M. Oya
Article
Biochemistry & Molecular Biology
Jarrod Sonett, Monica Goldklang, Piotr Sklepkiewicz, Adam Gerber, Jordis Trischler, Tina Zelonina, Marit Westerterp, Vincent Lemaitre, Yasunori Okada, Jeanine D'Armiento
Meeting Abstract
Orthopedics
M. Momoeda, H. Kaneko, L. Liu, S. Hada, H. Arita, T. Aoki, M. Kinosita, Y. Negishi, Y. Okada, K. Kaneko, M. Ishijima
OSTEOARTHRITIS AND CARTILAGE
(2018)
Meeting Abstract
Orthopedics
H. Kaneko, L. Liu, H. Arita, T. Aoki, Y. Negishi, M. Momoeda, S. Hada, Y. Okada, K. Kaneko, M. Ishijima
OSTEOARTHRITIS AND CARTILAGE
(2018)
Meeting Abstract
Orthopedics
S. Hada, M. Ishijima, H. Kaneko, L. Lizu, M. Kinoshita, H. Arita, T. Aoki, Y. Takazawa, H. Ikeda, Y. Tomita, K. Kusunose, Y. Okada, K. Kaneko
OSTEOARTHRITIS AND CARTILAGE
(2018)
Article
Pathology
Aya Sasaki, Hitoshi Abe, Satsuki Mochizuki, Masayuki Shimoda, Yasunori Okada
PATHOLOGY INTERNATIONAL
(2018)
Article
Dermatology
H. Yoshida, A. Komiya, R. Ohtsuki, A. Kusaka-Kikushima, S. Sakai, K. Kawabata, M. Kobayashi, S. Nakamura, A. Nagaoka, T. Sayo, Y. Okada, Y. Takahashi
SKIN RESEARCH AND TECHNOLOGY
(2018)
Article
Oncology
Naoya Niwa, Eiji Kikuchi, Kazuhiro Matsumoto, Takeo Kosaka, Ryuichi Mizuno, Mototsugu Oya
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
(2018)
Article
Biochemistry & Molecular Biology
Yuta Yoshino, Masamitsu Shimazawa, Shinsuke Nakamura, Shintaro Inoue, Hiroyuki Yoshida, Masayuki Shimoda, Yasunori Okada, Hideaki Hara
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2018)
Meeting Abstract
Oncology
Naoya Sakamoto, Ying Feng, Takuya Hattori, Masayuki Shimoda, Akira Ishikawa, Ririno Honma, Takao Hinoi, Hiroyuki Egi, Hideki Ohdan, Yasunori Okada, Eric Fearon, Wataru Yasui
Article
Endocrinology & Metabolism
Ryo Sadatsuki, Muneaki Ishijima, Haruka Kaneko, Lizu Liu, Ippei Futami, Shinnosuke Hada, Mayuko Kinoshita, Mitsuaki Kubota, Takako Aoki, Yuji Takazawa, Hiroshi Ikeda, Yasunori Okada, Kazuo Kaneko
JOURNAL OF BONE AND MINERAL METABOLISM
(2019)
Article
Urology & Nephrology
Kunihiro Yamagata, Joichi Usui, Michio Nagata, Hitoshi Sugiyama, Ken-ei Sada, Eri Muso, Masayoshi Harigai, Koichi Amano, Tatsuya Atsumi, Shouichi Fujimoto, Yukio Yuzawa, Masaki Kobayashi, Takao Saito, Takafumi Ito, Nobuhito Hirawa, Sakae Homma, Hiroaki Dobashi, Naotaka Tsuboi, Akihiro Ishizu, Yoshihiro Arimura, Hirofumi Makino, Seiichi Matsuo, Yoshinari Takasaki, Shogo Banno, Takahiko Sugihara, Yohko Murakawa, Hitoshi Hasegawa, Atsushi Komatsuda, Satoshi Ito, Takao Fujii, Atsushi Kawakami, Izaya Nakaya, Masahiro Yamamura, Masaaki Nakano, Kosaku Nitta, Makoto Ogura, Taio Naniwa, Shoichi Ozaki, Junichi Hirahashi, Noriyoshi Ogawa, Tatsuo Hosoya, Takashi Wada, Satoshi Horikoshi, Yasushi Kawaguchi, Taichi Hayashi, Masaharu Yoshida, Tsuyoshi Watanabe, Daijo Inaguma, Kazuhiko Tsuruya, Noriyuki Homma, Yasunori Okada, Tsutomu Takeuchi, Naoki Nakagawa, Shinichi Takeda, Ritsuko Katabuchi, Masayuki Iwano
CLINICAL AND EXPERIMENTAL NEPHROLOGY
(2019)
Article
Chemistry, Applied
H. Yoshida, K. Yamazaki, A. Komiya, M. Aoki, S. Kasamatsu, T. Murata, T. Sayo, M. Z. Cilek, Y. Okada, Y. Takahashi
INTERNATIONAL JOURNAL OF COSMETIC SCIENCE
(2019)
Article
Oncology
Frederik Konig, Nico C. Grossmann, Francesco Soria, David D'Andrea, Tristan Juvet, Aaron Potretzke, Hooman Djaladat, Alireza Ghoreifi, Eiji Kikuchi, Nozomi Hayakawa, Andrea Mari, Zine-Eddine Khene, Kazutoshi Fujita, Jay D. Raman, Alberto Breda, Matteo Fontana, John P. Sfakianos, John L. Pfail, Ekaterina Laukhtina, Pawel Rajwa, Maximilian Pallauf, Giovanni E. Cacciamani, Thomas van Doeveren, Joost L. Boormans, Alessandro Antonelli, Marcus Jamil, Firas Abdollah, Jeffrey Budzyn, Guillaume Ploussard, Axel Heidenreich, Siamak Daneshmand, Stephen A. Boorjian, Morgan Roupret, Michael Rink, Shahrokh F. Shariat, Benjamin Pradere
Summary: Measuring the quality of care is important in improving patient outcomes. In this study, five indicators were identified to assess the quality of care for patients with upper urinary tract cancer who undergo surgical removal of the affected kidney and ureter. Patients who achieved all five indicators had higher chances of survival and lower rates of recurrence. There were no patient-related factors that predicted a failure to achieve these indicators.
Article
Urology & Nephrology
Naoya Niwa, Tadashi Yoshida, Ryuichi Mizuno, Eiji Kikuchi, Akira Miyajima, Matsuhiko Hayashi, Mototsugu Oya
CLINICAL AND EXPERIMENTAL NEPHROLOGY
(2018)